News About: Pharm. Industry
10 multinationals spent 36.9 billion won as last year’s entertainment expenses
The combined entertainment expenses of the ten foreign-invested pharmaceutical firms were
36.9 billion won last year,
according to a report by the Financial Supervisory Service.
Aventis Pharma toppe...
Lilly willing to cooperate with Korean scientists over MDR-TB programs
Eli Lilly, a U.S.-based pharmaceutical company, plans to expand its research programs to fight multidrug-resistant tuberculosis (MDR-TB) with Korean scientists.
“We have talked with Korea’s research institutes incl...
Pfizer Korea to set up PK/PD hub center
Pfizer Korea plans to establish its PK/PD hub center to provide a fellowship program and a training program in Korea to educate researchers, as well as expand cooperation with Korean universities and institutes in maj...
Taejoon Pharm wins patent lawsuit against GE Healthcare
The Supreme Court ruled that Taejoon Pharm did not used patent-covered injection technology of contrast media developed by General Electric Healthcare, ending a three-year-long legal battle between the Korean firm and...
5-year sales trend of pharmaceutical firms and wholesalers outlined
According to statistics compiled by the Korea Tax Union, the growth rate of 75 pharmaceutical manufacturers in combined sales showed a fluctuating trend in a period ranging from 2003 to 2007, while that of 80 wholesal...
New insert papers for Ciprobay and Asprin are likely available in mid-April
Bayer Korea says that two old insert papers for Ciprobay and Asprin Protect are now being modified at the request of the Korea Food and Drug Administration and that new inserts papers for two products will be released...
Bae named as Novartis Korea DMR director
Bae Kyung-eun has been appointed director of Novaris Korea's DMR (Dermatological, Metabolic and Respiratory) unit following his position as a global brand director in the U.S. Novartis for two years.
A graduate of ...
Yungjin, Itochu sign MOU on cefcapene, third generation cephalosporin
Yungjin Pharm and Itochu Chemical Frontier Corporation, a global wide trading company in Japan, signed a memorandum of understanding on April 3 to enhance their strategic alliance in the field of pharmaceutical bulks....
Yuhan to go global with gastritis drug Revanex
Yuhan Corporation has been most active with its homegrown gastric acid pump antagonist Revanex (revaprazan) in exploring a number of overseas markets, including 10 countries in South America.
Yuhan says it signed a...
Release of Ciprobay and Aspirin Protects to be suspended for two months
Bayer Korea will suspend the supply of Ciprobay (ciprofloxacin) and Aspirin Protect to its associate wholesalers by the end of May, according to pharmaceutical business sources.
Bayer has requested wholesalers to p...
